FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...
In a report released today, Keay Nakae from Chardan Capital reiterated a Buy rating on Axcella Health (AXLA – Research Report), with a price...
H.C. Wainwright analyst Ed Arce maintained a Buy rating on Axcella Health (AXLA – Research Report) today and set a price target of $14.00. The...
In a report issued on May 5, Thomas Smith from SVB Securities maintained a Buy rating on Axcella Health (AXLA – Research Report), with a price...
2022Q1false0001633070--12-3100016330702022-01-012022-03-3100016330702022-04-29xbrli:shares00016330702022-03-31is...
Wedbush analyst Liana Moussatos reiterated a Buy rating on Axcella Health (AXLA – Research Report) today and set a price target of $10.00. The...
Our Fintel Significant Insider Buying Activity leaderboard has drawn us to take a look at AXLA, a stock that has an Insider Accumulation Score of...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington...
TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington...
After Noble Financial and Wedbush gave Axcella Health (NASDAQ: AXLA) a Buy rating last month, the company received another Buy, this time from...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.